# CERO THERAPEUTICS HLDGS INC \*W EXP 02/13/202

CERO THERAPEUTICS HLDGS INC *W EXP 02/13/202 is a security (CUSIP 71902K113) tracked across SEC portfolio filings. 3 institutional managers reported $11K on Form 13F as of 2025-06-30; 2 registered fund positions totaling $86 via N-PORT as of 2026-04-30.

## Summary

- Issuer: CERO THERAPEUTICS HLDGS INC
- Class: \*W EXP 02/13/202
- CUSIP: 71902K113
- Asset category: DE
- 13F holders: 3
- 13F value: $11K
- 13F period: 2025-06-30
- N-PORT fund positions: 2
- N-PORT value: $86
- N-PORT report: 2026-04-30

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| [Clear Street Derivatives LLC](https://search.stillhousedata.com/firm/90148) | NEW YORK, NY | $6K | 268,129 |
| [CLEAR STREET LLC](https://search.stillhousedata.com/firm/288933) | NEW YORK, NY | $5K | 193,824 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| Saba Capital Income & Opportunities Fund | Saba Capital Income & Opportunities Fund | $55 | 0.00% |
| [Calamos Market Neutral Income Fund](https://search.stillhousedata.com/fund/S000004062) | CALAMOS INVESTMENT TRUST/IL | $31 | 0.00% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/71902K113.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.